Mereo Biopharma Group Plc (MREO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access MREO Annual Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Mereo Biopharma Group Plc adapts its asset base and funding mix.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent30.12
Cash And Cash Equivalents0.39
Cash & Short-term Investments30.00
Notes Receivable, Current0.24
Other Current Assets1.00
Prepaid Expense And Other Assets Current1.66
Total Current Assets33.40
Equipment/Property/Plant Net1.07
Intangible Assets0.26
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent0.00
Research And Development Incentives Receivables Current1.56
Total Assets34.71
Liabilities
Accounts Payable, Current AC1.12
Accrued Liabilities, Current AC2.46
Other Liabilities, Current1.32
Taxes Payable0.79
Total Current Liabilities5.68
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE0.02
Noncurrent Provisions0.37
Total Liabilities6.06
Stockholders' Equity
Common Stock Value3.15
Additional Paid In Capital Common Stock552.34
Retained Earnings / Accumulated Deficit-514.54
Accumulated Other Comprehensive Income-12.29
Other Equity-12.29
Common Stockholder's Equity28.65
Total Stockholder's Equity28.65
Liabilities & Stockholder's Equity34.71
4 historic quarters locked

Sign in to unlock the full Mereo Biopharma Group Plc balance sheet history.

About Mereo Biopharma Group Plc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-343533

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.